Big Data Analytics in Healthcare Market Seeing 19.1% CAGR to 2025
/
Date23 Mar 2019
Email Print Friendly Share Portland, OR, March 22, 2019 (GLOBE NEWSWIRE) — According to this latest research study, titled, “Big Data Analytics in Healthcare Market by... Read More →
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO
/
Date23 Mar 2019
Email Print Friendly Share New Orleans, US, 23 March 2019 – Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared... Read More →
FEMSA Shareholders Approved Ps. 9,692 Million Dividend
/
Date23 Mar 2019
Email Print Friendly Share MONTERREY, Mexico, March 22, 2019 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (NYSE: FMX; BMV: FEMSAUBD) (“FEMSA” or “the... Read More →
Fronsac Announces Its Results for the Year Ended December 31, 2018 and Monthly Distributions for the Months of April, May and June 2019
/
Date23 Mar 2019
Email Print Friendly Share MONTREAL, March 22, 2019 (GLOBE NEWSWIRE) — (TSX-V: FRO.UN) Fronsac Real Estate Investment Trust (“Fronsac REIT” or “Fronsac”) announces its results... Read More →
NW Natural Water Signs Agreements to Purchase Water Companies in Idaho and Washington
/
Date23 Mar 2019
Email Print Friendly Share PORTLAND, Ore., March 22, 2019 (GLOBE NEWSWIRE) — NW Natural Water Company, LLC (NW Natural Water), a subsidiary of Northwest Natural... Read More →
Domo Raises the User Experience Bar Again With Domo Stories
/
Date23 Mar 2019
Email Print Friendly Share SILICON SLOPES, Utah, March 21, 2019 (GLOBE NEWSWIRE) — Domopalooza 2019 — Today Domo (Nasdaq: DOMO) announced Domo Stories, a new feature set that... Read More →
Byggðastofnun – Ársreikningur 2018
/
Date23 Mar 2019
Email Print Friendly Share Ársreikningur Byggðastofnunar 2018 Ársreikningur Byggðastofnunar fyrir árið 2018, var staðfestur af stjórn stofnunarinnar 22. mars 2019Hagnaður ársins nam 113,4 milljónum króna. ... Read More →
FDA Issues Complete Response Letter for Zynquista™ (sotagliflozin)
/
Date23 Mar 2019
Email Print Friendly Share PARIS and THE WOODLANDS, Texas, March 22, 2019 (GLOBE NEWSWIRE) — The U.S. Food and Drug Administration (FDA) issued a Complete... Read More →
Hoth Therapeutics Inc. Announces Closing of Initial Public Offering
/
Date23 Mar 2019
Email Print Friendly Share NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) — Hoth Therapeutics Inc. (NASDAQ: HOTH), a development stage biopharmaceutical company focused on unique... Read More →